Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
UA-Affiliated company producing early disease detection technology
[Source: University of Arizona Communications] - Part of the difficulty in detecting diseases like cancer early on is that the instruments available to hunt for the minute proteins indicative of a disease are not advanced enough.
The evidence is often right in the bloodstream but "blood tests are not always sensitive enough," said Mary J. Wirth, a University of Arizona chemistry professor and chemical analyst. "The key is to develop more sensitive tools for research and clinical diagnostics."
Detecting diseases before the onset of symptoms, she said, is one of the greatest challenges in modern-day medicine.
For more information click here.
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
